Concepedia

Erika Englund

EE

6

Publications

220

Citations

6

H-Index

2003

Active since

Affiliations

Abbott Fund(Current)

Erika Englund is an author at Abbott Fund specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2003–2017

6

Publications

6

Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors

Jun R. Huh, Erika Englund, Hang Wang et al. · ACS Medicinal Chemistry Letters · 2012 · 64 citations · Full text

FDA Approval Summary: TAS-102

Leigh Marcus, Steven J. Lemery, Sachia G. Khasar et al. · Clinical Cancer Research · 2017 · 55 citations · Full text

Synthesis and Antibacterial Activity of 6-<i>O</i>-Arylbutynyl Ketolides with Improved Activity against Some Key Erythromycin-Resistant Pathogens

Robert F. Keyes, Justin J. Carter, Erika Englund et al. · Journal of Medicinal Chemistry · 2003 · 45 citations

, , +15

Novel AntibacterialClass

Peter J. Dandliker, Steve D. Pratt, Angela M. Nilius et al. · Antimicrobial Agents and Chemotherapy · 2003 · 35 citations · Full text

The synthesis and evaluation of dihydroquinazolin-4-ones and quinazolin-4-ones as thyroid stimulating hormone receptor agonists

Erika Englund, Susanne Neumann, Elena Eliseeva et al. · MedChemComm · 2011 · 11 citations · Full text

, , +14

Rows per page

1–5 of 6